retatrutide news october 2025 Eli Lilly says next-generation weight loss drug clears crucial obesity trial Lilly's Retatrutide Scores Triple Trial
Description
This nuance made the topic especially rich for discussion in academic and media circles
Nausea is a frequently reported side effect for many people starting GLP-1 medications
University of Washington, Seattle, Seattle (WA (1993)
Across both campaigns, our ambassadors arent just spokespeople
Rapid weight loss can accelerate muscle loss if not properly managed
Conversely, many patients may experience improved sexual function with weight loss
